http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2487846-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d53094985a54e1cafd22f23d76be4007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0057723f147cb808e00f42630022d52
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
filingDate 2003-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4d6d0f974a93d09594119c7ddb60abd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b00f4798f10fa876f85aa220c9586f0
publicationDate 2003-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2487846-A1
titleOfInvention Method, composition and kit for antigenic binding of norwalk-like viruses
abstract A method for detecting a Norwalk-Like Virus (NLV) in a biological sample, comprising the steps of: obtaining a biological sample suspected of containing a NLV; contacting the biological sample with at least one human histo-blood group antigen to allow formation of a complex of the NLV with the antigen; and detecting the antigen NLV complex. The antigen-NLV complex can be detected by contacting the NLV-antigen complex with a NLV antibody that binds at an epitope of the NLV, and detecting the NLV antibody. The invention also includes a method for identifying compounds, and the compounds, that can inhibit the binding between a Norwalk-Like Virus (NLV) and a histo-blood group antigen. The method includes the steps of contacting the NLV target with a compound; subsequently contacting the NLV with a standard compound that is known to be bound at a determinant binding site of the NLV; and determining whether the binding of the standard compound is decreased in the presence of the test compound, the decrease in binding being an indication that the test compound inhibits the binding activity of the NLV with the standard compound. In preferred embodiments, the standard compound is a histo-blood group antigen.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096644-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9321803-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9561239-B2
priorityDate 2002-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419564493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423371041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45480569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456491132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456490786
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53262342

Total number of triples: 33.